Modifications of microvascular EC surface modulate phototoxicity of a porphycene anti-ICAM-1 immunoconjugate; Therapeutic implications

Langmuir

Volumn 29, Issue 31, 2013, Pages 9734-9743

  Rosàs, Elisabet ^a,b   Santomá, Pablo ^a,b   Duran Frigola, Miquel ^a,b   Hernandez, Bryan ^a,b   Llinàs, Maria C ^b   Ruiz González, Rubén ^b   Nonell, Santi ^b   Sánchez García, David ^b   Edelman, Elazer R ^a,c   Balcells, Mercedes ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b Institut Químic de Sarrià Universitat Ramon Llull   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR ADHESION MOLECULES; ICAM-1 EXPRESSION; IMMUNOCONJUGATE; IMMUNOTARGETING; MICRO-VASCULATURE; MICROVASCULAR; PHOTO-TOXICITY; PHOTODYNAMIC THERAPY (PDT);

ENDOTHELIAL CELLS; PHOTODYNAMIC THERAPY;

BLOOD VESSELS;

EID: 84881434257     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la401067d     Document Type: Article

References (54)

1. Aird, W. C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms Circulation 2007, 100 (2) 158-73 http://www.ncbi.nlm. nih.gov/pubmed/17272818
2. Félétou, M. The Endothelium: Part 1: Multiple Functions of the Endothelial Cells-Focus on Endothelium-Derived Vasoactive Mediators [Online] Morgan & Claypool Life Sciences: San Rafael, CA, 2011; http://www.ncbi.nlm. nih.gov/books/NBK57149/.
3. Morigi, B. M.; Zoja, C.; Figliuzzi, M.; Foppolo, M.; Micheletti, G.; Bontempelli, M. Fluid Shear Stress Modulates Surface Expression of Adhesion Molecules Blood 1995, 85 (7) 1696-703
4. Sheikh, S.; Rainger, G. E.; Gale, Z.; Rahman, M.; Nash, G. B. Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-alpha: a basis for local variations in vascular sensitivity to inflammation Blood 2003, 102 (8) 2828-34 http://www.ncbi.nlm.nih.gov/pubmed/12829609
5. Burke-Gaffney, A.; Hellewell, P. G. Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: modulation by tyrosine kinase inhibitors Br. J. Pharmacol. 1996, 119 (6) 1149-58 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1915891&tool= pmcentrez&rendertype=abstract
6. Davies, P. F. Hemodynamic shear stress and the endothelum in cardiovascular pathophysiology Nat. Clin. Pract. Cardiovasc. Med. 2010, 6 (1) 16-26
7. Sheski, F.; Natarajan, V.; Pottratz, S. T. Tumor necrosis factor-α stimulates attachment of small cell lung carcinoma to endothelial cells J. Lab. Clin. Med. 1999, 133 (3) 265-73
8. Muzykantov, V. R.; Atochina, E. N.; Ischiropoulos, H.; Danilovt, S. M.; Fisher, A. B. Immunotargeting of antioxidant enzymes to the pulmonary endothelium Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (May) 5213-8
9. Kamizuru, H.; Kimura, H.; Yasukawa, T.; Tabata, Y.; Honda, Y.; Ogura, Y. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat Invest. Ophthalmol. Vis. Sci. 2001, 42 (11) 2664-72 http://www.ncbi.nlm. nih.gov/pubmed/11581214
10. Kozower, B. D.; Christofidou-Solomidou, M.; Sweitzer, T. D.; Muro, S.; Buerk, D. G.; Solomides, C. C. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury Nat. Biotechnol. 2003, 21 (4) 392-8 http://www.ncbi.nlm.nih.gov/pubmed/ 12652312
11. Winter, P. M.; Neubauer, A. M.; Caruthers, S. D.; Harris, T. D.; Robertson, J. D.; Williams, T a Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26 (9) 2103-9 http://www.ncbi.nlm.nih.gov/pubmed/16825592
12. Wu, H.; Li, P. Proteins Expressed on Tumor Endothelial Cells as Potential Targets for Anti-Angiogenic Therapy Journal of Cancer Molecules 2008, 4 (1) 17-22
13. Bhowmick, T.; Berk, E.; Cui, X.; Muzykantov, V. R.; Muro, S. Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1 Journal of Controlled Release 2012, 157 (3) 485-92 http://www.ncbi.nlm.nih.gov/pubmed/ 21951807
14. Ding, B.; Dziublam, T.; Shuvaev, V.; Muro, S.; Muzykantov, V. Advanced drug delivery systems that target the vascular endothelium Molecular Interventions 2006, 6 (2) 98-112
15. Muro, S.; Dziubla, T.; Qiu, W.; Leferovich, J.; Cui, X.; Berk, E. Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1 J. Pharmacol. Exp. Therapeutics 2006, 317 (3) 1161-9
16. Rothlein, R.; Dustin, M. L.; Marlin, S. D.; Springer, T a. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1 J. Immunol. 1986, 137 (4) 1270-4 http://www.ncbi.nlm.nih.gov/pubmed/3525675
17. Pober, J. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells Ciba Foundation Symposium 1987, 131, 170-84
18. Muro, S.; Gajewski, C.; Koval, M.; Muzykantov, V. R. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs Blood 2005, 105 (2) 650-8 http://www.ncbi.nlm.nih. gov/pubmed/15367437
19. Staneloudi, C.; Smith, K. a.; Hudson, R.; Malatesti, N.; Savoie, H.; Boyle, R. W. Development and characterization of novel photosensitizer: scFv conjugates for use in photodynamic therapy of cancer Immunology 2007, 120 (4) 512-7 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2265903&tool=pmcentrez&rendertype=abstract
20. Smith, K.; Malatesti, N.; Cauchon, N.; Hunting, D.; Lecomte, R.; Van Lier, J. E. Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action Immunology 2011, 132 (2) 256-65 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3045661&tool= pmcentrez&rendertype=abstract
21. Ragàs, X.; Sánchez-García, D.; Ruiz-González, R.; Dai, T.; Agut, M.; Hamblin, M. R. Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy J. Med. Chem. 2010, 53 (21) 7796-803 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2981434&tool=pmcentrez&rendertype=abstract
22. Clarke, O. J. Boyle RW. Isothiocyanatoporphyrins, useful intermediates for the conjugation of porphyrins with biomolecules and solid supports Chem. Commun. 1999, 21, 2231-2
23. Hudson, R.; Carcenac, M.; Smith, K.; Madden, L.; Clarke, O. J.; Pèlegrin, A. The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy Br. J. Cancer 2005, 92 (8) 1442-9 http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=2362018&tool=pmcentrez&rendertype=abstract
24. Carmeliet, P. Angiogenesis in health and disease Nat. Med. 2003, 9 (6) 653-60 http://www.ncbi.nlm.nih.gov/pubmed/12778163
25. Roberts, W. G.; Palade, G. E.; Palade, E. Neovasculature Induced by Vascular Endothelial Growth Factor Is Fenestrated Cancer Res. 1997, 57, 765-72
26. Griffioen, a W; Molema, G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation Pharmacol. Rev. 2000, 52 (2) 237-68 http://www.ncbi.nlm.nih.gov/ pubmed/10835101
27. Winter, P. M.; Neubauer, A. M.; Caruthers, S. D.; Harris, T. D.; Robertson, J. D.; Williams, T a Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26 (9) 2103-9 http://www.ncbi.nlm.nih.gov/pubmed/16825592
28. Moreno, P. R.; Purushothaman, K-R; Sirol, M.; Levy, A. P.; Fuster, V. Neovascularization in human atherosclerosis Circulation 2006, 113 (18) 2245-52 http://www.ncbi.nlm.nih.gov/pubmed/16684874
29. Yasukawa, T.; Hoffmann, S.; Eichler, W.; Friedrichs, U.; Wang, Y.; Wiedemann, P. Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist Curr. Eye Res. 2004, 28 (5) 359-66
30. Danhier, F.; Vroman, B.; Lecouturier, N.; Crokart, N.; Pourcelle, V.; Freichels, H. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel J. Controlled Rel. 2009, 140 (2) 166-73 http://www.ncbi.nlm.nih.gov/pubmed/19699245
31. Balcells, M.; Fernández Suárez, M.; Vázquez, M.; Edelman, E. R. Cells in fluidic environments are sensitive to flow frequency J. Cell. Physiol. 2005, 204 (1) 329-35 http://www.ncbi.nlm.nih.gov/pubmed/15700266
32. Carcenac, M.; Larroque, C.; Langlois, R.; Van Lier, J. E.; Artus, J. C. Pèlegrin a. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates Photochem. Photobiol. 1999, 70 (6) 930-6 http://www.ncbi.nlm.nih.gov/pubmed/ 10628305
33. Hayden, M. R.; Tyagi, S. C. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation Cardiovascular Diabetology 2004, 16 (1575) 1-16
34. Sainson, RC a; Johnston, D a; Chu, H. C.; Holderfield, M. T.; Nakatsu, M. N.; Crampton, S. P. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype Blood 2008, 111 (10) 4997-5007 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2384130&tool= pmcentrez&rendertype=abstract
35. Lan, Z.; Nonell, S.; Barbatti, M. Theoretical Characterization of Absorption and Emission Spectra of an Asymmetric Porphycene J. Phys. Chem. A 2012, 116 (13) 3366-76
36. Agostinis, P.; Berg, K.; Cengel, K. A.; Foster, T. H.; Girotti, A. W.; Gollnick, S. O. Photodynamic Therapy of Cancer: An Update CA Cancer J. Clin. 2011, 61, 250-81
37. Vrouenraets, M. B.; Visser, G. W.; Stewart, F a; Stigter, M.; Oppelaar, H.; Postmus, P. E. Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy Cancer Res. 1999, 59 (7) 1505-13 http://www.ncbi.nlm.nih.gov/pubmed/10197621
38. Waksman, R.; McEwan, P.; Moore, T.; Pakala, R.; Kolodgie, F.; Hellinga, D. PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression J. Am. Coll. Cardiol. 2008, 52 (12) 1024-32
39. Stockert, J. C.; Canete, M.; Juarranz, A.; Villanueva, A.; Horobin, R. W.; Borrell, J. I. Porphycenes: Facts and Prospects in Photodynamic Therapy of Cancer Curr. Med. Chem. 2007, 14 (9) 997-1026
40. Gawinkowski, S.; Orzanowska, G.; Izdebska, K.; Senge, M. O.; Waluk, J. Bridging the gap between porphyrins and porphycenes: substituent-position- sensitive tautomerism and photophysics in meso-diphenyloctaethylporphyrins Chemistry (Weinheim an der Bergstrasse, Germany) 2011, 17 (36) 10039-49 http://www.ncbi.nlm.nih.gov/pubmed/21796691
41. Rubio, N.; Prat, F.; Bou, N.; Borrell, J. I.; Teixidó, J.; Villanueva, á A comparison between the photophysical and photosensitising properties of tetraphenyl porphycenes and porphyrins New J. Chem. 2005, 29, 378-84
42. Packard, R. R. S.; Libby, P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clin. Chem. 2008, 54 (1) 24-38 http://www.ncbi.nlm.nih.gov/pubmed/18160725
43. Methe, H.; Balcells, M.; Alegret, M. D. C.; Santacana, M.; Molins, B.; Hamik, A. Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression Am. J. Physiol. 2007, 292 (5) H2167-75 http://www.ncbi.nlm.nih.gov/pubmed/17209004
44. Luscinskas, F. W.; Gimbrone, M a. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment Annu. Rev. Med. 1996, 47, 413-21 http://www.ncbi.nlm.nih.gov/pubmed/8712792
45. Virmani, R.; Kolodgie, F. D.; Burke, A. P.; Finn, A V; Gold, H. K.; Tulenko, T. N. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25 (10) 2054-61 http://www.ncbi.nlm.nih.gov/pubmed/ 16037567
46. Doyle, B.; Caplice, N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis J. Am. Coll. Cardiol. 2007, 49 (21) 2073-80 http://www.ncbi.nlm.nih.gov/pubmed/17531655
47. Vuorio, T.; Jauhiainen, S.; Ylä-Herttuala, S. Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors Expert Opin. Biol. Therapy 2012, 12 (1) 79-92 http://www.ncbi.nlm.nih.gov/pubmed/22115316
48. Slevin, M.; Krupinski, J.; Badimon, L. Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention J. Angiogenesis Res. 2009, http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2776234&tool=pmcentrez&rendertype=abstract
49. Moulton, K. S.; Vakili, K.; Zurakowski, D.; Soliman, M.; Butterfield, C.; Sylvin, E. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (8) 4736-41 http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=153625&tool=pmcentrez&rendertype=abstract
50. Muller, J. E. New light on an old problem photodynamic therapy for atherosclerosis J. Am. Coll. Cardiol. 2008, 52 (12) 1033-4 http://www.ncbi.nlm. nih.gov/pubmed/18786487
51. Olivo, M.; Bhuvaneswari, R.; Lucky, S. S.; Dendukuri, N.; Soo-Ping Thong, P. Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities Pharmaceuticals 2010, 3 (5) 1507-29 http://www.mdpi.com/1424-8247/3/5/1507/
52. Bhuvaneswari, R.; Gan, Y. Y.; Soo, K. C.; Olivo, M. The effect of photodynamic therapy on tumor angiogenesis Cell. Mol. Life Sci. 2009, 66 (14) 2275-83 http://www.ncbi.nlm.nih.gov/pubmed/19333552
53. He, C.; Fateye, B.; Chen, B.; Kessel, D. H. Combination of vascular targeting PDT with combretastatin A4 phosphate Photodynamic Therapy: Back to the Future 2009, 738032-738032-6 http://proceedings.spiedigitallibrary.org/ proceeding.aspx?articleid=782589
54. Spragg, D. D.; Alford, D. R.; Greferath, R.; Larsen, C. E.; Lee, K. D.; Gurtner, G. C. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (16) 8795-800 http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid=23135&tool=pmcentrez&rendertype=abstract